Mucous membrane pemphigoid following reduced intensity conditioning allogeneic haematopoietic SCT for biphenotypic leukaemia

Bone Marrow Transplantation

Volumn 45, Issue 1, 2010, Pages 195-196

  Mahmood, S ^a   Lim, Z Y ^a   Benton, E ^a   Du Vivier, A ^a   Bhogal, B ^b   Mufti, G J ^a   Pagliuca, A ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BUSULFAN; CYCLOSPORIN; EYE DROPS; FLUDARABINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; STEROID;

ACUTE BIPHENOTYPIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; BRONCHOSCOPY; CASE REPORT; CD34 SELECTION; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVITIS; COUGHING; EYE DISCHARGE; EYE DISEASE; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; INFECTION; LABORATORY TEST; LETTER; MALE; MUCOUS MEMBRANE PEMPHIGOID; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENT FEVER; REDUCED INTENSITY CONDITIONING; SORE THROAT; WEIGHT REDUCTION;

GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 75149118273     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.98     Document Type: Letter

References (9)

1. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment and prognostic indicators. Arch Dermatol 2002; 138: 370-379.
2. Seth RK, Su GW, Pflugfelder SC. Mucous membrane pemphigoid in a patient with chronic lymphocytic leukaemia. Cornea 2004; 23: 740-743.
3. Aisa Y, Mori T, Nakazato T, Yamazaki R, Yamagami J, Amagai M et al. Cicatricial pemphigoid of the oropharynx after allogeneic stem cell transplantation for relapsed follicular lymphoma. Int J Hematol 2005; 82: 266-269.
4. Saravanan K, Baer ST, Meredith A, Dyson A, von der Werth J. Benign mucous membrane pemphigoid of the upper aerodigestive tract: rare paraneoplastic syndrome presentation in renal cell carcinoma. J Laryngol Otol 2006; 120: 237-239.
5. Rutar T, Chan MF, Acharya NR, Naseri A. Cicatrising conjunctivitis due to paraneoplastic pemphigoid. Br J Opthalmol 2007; 91: 1562-1563.
6. Setterfield J, Shirlaw PJ, Lazarova Z, Bryant BM, Bhogal BS, Harman K et al. Paraneoplastic cicatricial pemphigoid. Br J Dermato 1999; 141: 127-131.
7. Egan CA, Lazarova Z, Darling TN, Yee C, Yancey KB. Antiepiligrin cicatricial pemphigoid and relative risk of cancer. Lancet 2001; 357: 1850-1851.
8. Setterfield J, Theron J, Vaughn RW, Welsh KI, Mallon E, Wojnarowska F et al. Mucous membrane pemphigoid: HLADQB1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol 2001; 145: 406-414.
9. Izumi R, Fujimoto M, Yazawa N, Nakashima H, Asashima N, Watanabe R et al. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-hostdisease. J Am Acad Dermatol 2007; 56: s94-s97.